Publicaciones
-
Lorito N, Subbiani A, Smiriglia A, Bacci M, Bonechi F, Tronci L, Romano E, Corrado A, Longo DL, Iozzo M, Ippolito L, Comito G, Giannoni E, Meattini I, Avgustinova A, Chiarugi P, Bachi A and Morandi A.
FADS1/2 control lipid metabolism and ferroptosis susceptibility in triple-negative breast cancer.
EMBO Molecular Medicine . 16(7): 1533-1559. Nº de citas: 2
-
Sanchez-Guixe E, Muiños F, Pinheiro-Santin M, González-Huici V, Rodriguez-Hernandez CJ, Avgustinova A, Lavarino C, González- Pérez A, Mora J and López-Bigas N.
Origins of Second Malignancies in Children and Mutational Footprint of Chemotherapy in Normal Tissues
CANCER DISCOVERY . 14(6): 953-964. Nº de citas: 2
-
Llorente A, Blasco MT, Espuny I, Guiu M, Ballaré C, Blanco E, Caballé A, Bellmunt A, Salvador F, Morales A, Nuñez M, Loren G, Imbastari F, Fidalgo M, Figueras-Puig C, Gibler P, Graupera M, Monteiro F, Riera A, Holen I, Avgustinova A, Di Croce L and Gomis RR.
MAF amplification licenses ERa through epigenetic remodelling to drive breast cancer metastasis
NATURE CELL BIOLOGY . : 1833-1847.
-
Figuerola-Bou E, Rios-Astorch C, Blanco E, Sanchez-Jimenez M, Táboas-Outón P, Fernandez-Isern G, Gomez-Gonzalez S, Muñoz-Aznar O, Castellano P, Pérez-Jaume S, Prada-Varela E, Mateo-Lozano S, Riggi N, Avgustinova A, Lavarino C, Di Croce L, Sánchez-Molina S and Mora J.
KDM6 demethylases mediate EWSR1-FLI1-driven oncogenic transformation in Ewing Sarcoma
Biorxiv . : .
-
Jenkins L, Jungwirth U, Avgustinova A, Iravani M, Mills AP, Haider S, Harper J and Isacke CM.
Cancer-Associated Fibroblasts Suppress CD8(+ )T-cell Infiltration and Confer Resistance to Immune-Checkpoint Blockade
CANCER RESEARCH . 82(16): 2904-2917. Nº de citas: 100
-
Avgustinova A, Laudanna C, Pascual-García M, Rovira Q, Djurec M, Castellanos A, Urdiroz-Urricelqui U, Marchese D, Prats N, Van Keymeulen A, Heyn H, Vaquerizas JM and Benitah SA.
Repression of endogenous retroviruses prevents antiviral immune response and is required for mammary gland development.
Cell stem cell . 28(10): 1790. Nº de citas: 7
-
Avgustinova A, Symeonidi A, Castellanos A, Urdiroz-Urricelqui U, Solé-Boldo L, Martín M, Pérez-Rodríguez I, Prats N, Lehner B, Supek F and Benitah SA.
Loss of G9a preserves mutation patterns but increases chromatin accessibility, genomic instability and aggressiveness in skin tumours.
NATURE CELL BIOLOGY . 20(12): 1400-1409. Nº de citas: 29
-
Li H, Yao Q, Mariscal AG, Wu X, Hülse J, Pedersen E, Helin K, Waisman A, Vinkel C, Thomsen SF, Avgustinova A, Benitah SA, Lovato P, Norsgaard H, Mortensen MS, Veng L, Rozell B and Brakebusch C.
Epigenetic control of IL-23 expression in keratinocytes is important for chronic skin inflammation.
NATURE COMMUNICATIONS . 9(1): 1420-1420. Nº de citas: 91
-
Rinaldi L, Avgustinova A, Martín M, Datta D, Solanas G, Prats N and Aznar Benitah S.
Loss of Dnmt3a and Dnmt3b does not affect epidermal homeostasis but promotes squamous transformation through PPAR-?.
eLife . 6: . Nº de citas: 42
-
Pascual G, Avgustinova A, Mejetta S, Martín M, Castellanos A, Attolini CS, Berenguer A, Prats N, Toll A, Hueto JA, Bescós C, Di Croce L and Aznar Benitah S.
Targeting metastasis-initiating cells through the fatty acid receptor CD36.
Nature . 541(7635): 41-45. Nº de citas: 927